<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>LY530138</GBSeq_locus>
    <GBSeq_length>2051</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>26-SEP-2018</GBSeq_update-date>
    <GBSeq_create-date>26-SEP-2018</GBSeq_create-date>
    <GBSeq_definition>KR 1020170102328-A/313: HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN</GBSeq_definition>
    <GBSeq_primary-accession>LY530138</GBSeq_primary-accession>
    <GBSeq_accession-version>LY530138.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|LY530138.1|</GBSeqid>
      <GBSeqid>pat|KR|1020170102328|313</GBSeqid>
      <GBSeqid>gi|1483446799</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020170102328-A/313</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Ebola virus (EBOV)</GBSeq_source>
    <GBSeq_organism>Ebola virus</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; ssRNA viruses; ssRNA negative-strand viruses; Mononegavirales; Filoviridae; Ebolavirus</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..2051</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Kyratsous,C.</GBAuthor>
          <GBAuthor>Olson,W.</GBAuthor>
          <GBAuthor>Mason,P.</GBAuthor>
          <GBAuthor>Stahl,N.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN</GBReference_title>
        <GBReference_journal>KR1020170102328-A 313 08-SEP-2017 REGENERON PHARMACEUTICALS, INC</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020177021579-A/313~AN KR 1020177021579~AD 2017-08-01~PN KR 1020170102328~PD 2017-09-08~AT HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN~AI Kyratsous, Christos|Olson, William|Mason, Peter|Stahl, Neil~AA REGENERON PHARMACEUTICALS, INC.~PR US 62/107,581=2015-01-26|US 62/161,356=2015-05-14|US~PR 62/245,703=2015-10-23~OS Ebola virus~TY DNA~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..2051</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>2051</GBInterval_to>
            <GBInterval_accession>LY530138.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Ebola virus</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:1570291</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>gaattcgccaccatgggcgtgaccggcatcctgcagctgccccgggacagattcaagcggaccagcttcttcctgtgggtcatcatcctgttccagcggaccttcagcatccccctgggcgtgatccacaacagcaccctgcaggtgtccgacgtggacaagctcgtgtgccgggacaagctgagcagcaccaaccagctgagaagcgtgggcctgaacctggaaggcaatggcgtggccaccgatgtgcctagcgccaccaagagatggggcttcagatccggcgtgccccccaaggtcgtgaattatgaggccggcgagtgggccgagaactgctacaacctggaaatcaagaagcccgacggcagcgagtgcctgcctgctgcccctgatggcatcagaggcttcccccggtgcagatacgtgcacaaggtgtccggcacaggcccctgcgctggcgatttcgcctttcacaaagagggcgcctttttcctgtacgaccggctggcctccaccgtgatctacagaggcaccacctttgccgagggcgtggtggcctttctgatcctgcctcaggccaagaaggacttcttcagcagccaccccctgcgcgagcctgtgaatgccacagaggatcccagcagcggctactacagcaccaccatcagataccaggccaccggcttcggcaccaacgagacagagtacctgttcgaggtggacaacctgacctacgtgcagctggaaagccggttcaccccccagtttctgctgcagctgaacgagacaatctacgccagcggcaagcggagcaacaccaccggcaagctgatctggaaagtgaaccccgagatcgataccacaatcggagagtgggccttctgggagacaaagaagaacctgacccggaagatcagaagcgaggaactgagcttcaccgccgtgtccaacggccccaagaacatcagcggacagagccccgccagaaccagcagcgaccccgagacaaacaccaccaatgaggaccacaagatcatggccagcgagaacagcagcgccatggtgcaggtgcacagccagggaagaaaggccgctgtgtcccacctgaccaccctggccacaatctccaccagccctcagagcctgaccacaaagcctggccccgacaactccacccacaacacccccgtgtacaagctggacatcagcgaggccacacaagtgggccagcaccacagaagggccgacaacgatagcaccgccagcgatacccctccagccacaactgctgccggacctctgaaggccgagaataccaacaccagcaagagcgccgacagcctggatctggccaccaccacaagcccccagaactactctgagacagccggcaacaacaacacccaccaccaggataccggcgaggaaagcgccagctctggcaagctgggactgatcaccaacacaatcgccggcgtggccggcctgattaccggggggagaagaaccagacgggaagtgatcgtgaacgcccagcccaagtgcaaccccaacctgcactactggaccacccaggatgagggcgctgctatcggactggcctggatcccttactttggccctgccgccgagggcatctacaccgagggactgatgcacaaccaggacggcctgatctgcggactgaggcagctggccaacgaaaccacacaggctctgcagctgttcctgagagccaccaccgagctgaggaccttctccatcctgaacagaaaggctatcgacttcctgctgcagcgctggggcggcacctgtcacattctgggccctgactgctgcatcgagccccacgactggaccaagaatatcaccgacaagatcgaccagatcatccacgactttgtggacaagaccctgcccgaccagggcgacaatgacaactggtggacaggctggcggcagtggattcctgccggcattggagtgaccggcgtgatcattgccgtgatcgccctgttctgcatctgcaagttcgtgttctgagcggccgc</GBSeq_sequence>
  </GBSeq>
